Dr Nicholas Hardcastle
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
295 Scholarly works
7 Projects
HIGHLIGHTS
2026
Journal article
Deep learning and radiomics models in patients with advanced non-small cell lung cancer treated with immunotherapy combined with stereotactic radiotherapy
DOI: 10.1038/s41598-026-53520-52026
Journal article
Standardization of breast radiotherapy structure nomenclature using transformer-based multi-modal feature learning
DOI: 10.1016/j.bspc.2026.1109062026
Journal article
A real-time image-guided six-degree-of-freedom internal-external correlation framework for motion monitoring on a standard linear accelerator
DOI: 10.1088/1361-6560/ae9e812026
Journal article
Blood dosimetry during volumetric modulated arc therapy for non-small cell lung cancer: A time-resolved model of circulating particles
DOI: 10.1016/j.ejmp.2026.1059102026
Research grants (other domestic)
Evaluating the Effect of Radiotherapy on the Musculoskeletal Growth of Paediatric Patients Using Anatomical Mapping Models
2024
Research grants (other domestic)
Next-Generation Radiotherapy Treatment Planning With Artificial Intelligence
2022
Research grants (other domestic)
Sitting Up for Radiotherapy
RECENT SCHOLARLY WORKS
2026
Journal article
Version upgrades in treatment planning Systems affect clinical application of a multi-Centre knowledge-based planning model
DOI: 10.1016/j.tipsro.2026.1004172026
Journal article
Radiation Therapy Target Objectives for Tonsillar Cancer Treated With Unilateral Radiation Therapy—A Replanning Study From TROG 12.01
DOI: 10.1016/j.ijrobp.2025.12.0582026
Journal article
Stereotactic Ablative Radiotherapy (SABR) one stop service for lung cancer: A pilot study for early-stage Non-Small-Cell Lung Cancer (NSCLC)
DOI: 10.1016/j.radonc.2026.1115532026
Journal article
Correction: Investigating the Prognostic Value of Pretreatment Body Composition in Women with Ovarian Cancer: Impact on Clinical Outcomes (Cancers, (2026), 18, 9, (1478), 10.3390/cancers18091478)
DOI: 10.3390/cancers181320552026
Journal article
Special Issue on Sustainability
DOI: 10.1111/1754-9485.701362026
Journal article
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials
DOI: 10.1016/S1470-2045(26)00170-1
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
A Registry-Based Randomised Trial of Radiotherapy in Advanced Lung Cancer
2024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases